Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

FRA:B7E - Deutsche Boerse Ag - DE000A0JM2M1 - Common Stock - Currency: EUR

17  -0.2 (-1.16%)

Fundamental Rating

5

Overall B7E gets a fundamental rating of 5 out of 10. We evaluated B7E against 116 industry peers in the Capital Markets industry. Both the profitability and the financial health of B7E get a neutral evaluation. Nothing too spectacular is happening here. B7E is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

B7E had positive earnings in the past year.
In the past year B7E had a positive cash flow from operations.
B7E had positive earnings in 4 of the past 5 years.
In the past 5 years B7E always reported a positive cash flow from operatings.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

B7E's Return On Assets of 6.14% is fine compared to the rest of the industry. B7E outperforms 79.31% of its industry peers.
With a decent Return On Equity value of 13.94%, B7E is doing good in the industry, outperforming 74.14% of the companies in the same industry.
B7E has a better Return On Invested Capital (3.95%) than 64.66% of its industry peers.
The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 8.27%.
Industry RankSector Rank
ROA 6.14%
ROE 13.94%
ROIC 3.95%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

B7E has a Profit Margin (6.44%) which is in line with its industry peers.
In the last couple of years the Profit Margin of B7E has grown nicely.
B7E's Operating Margin of 4.18% is in line compared to the rest of the industry. B7E outperforms 52.59% of its industry peers.
In the last couple of years the Operating Margin of B7E has grown nicely.
B7E has a better Gross Margin (50.05%) than 65.52% of its industry peers.
In the last couple of years the Gross Margin of B7E has grown nicely.
Industry RankSector Rank
OM 4.18%
PM (TTM) 6.44%
GM 50.05%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The number of shares outstanding for B7E remains at a similar level compared to 1 year ago.
The number of shares outstanding for B7E has been increased compared to 5 years ago.
Compared to 1 year ago, B7E has an improved debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.15 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
B7E has a Altman-Z score of 2.15. This is in the better half of the industry: B7E outperforms 66.38% of its industry peers.
B7E has a debt to FCF ratio of 9.68. This is a negative value and a sign of low solvency as B7E would need 9.68 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 9.68, B7E is doing good in the industry, outperforming 68.97% of the companies in the same industry.
B7E has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.38, B7E is doing good in the industry, outperforming 65.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 9.68
Altman-Z 2.15
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

B7E has a Current Ratio of 1.65. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.65, B7E is doing good in the industry, outperforming 75.86% of the companies in the same industry.
B7E has a Quick Ratio of 1.36. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E's Quick ratio of 1.36 is fine compared to the rest of the industry. B7E outperforms 71.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.36
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

B7E shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 172.52%, which is quite impressive.
Measured over the past years, B7E shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.00% on average per year.
B7E shows a decrease in Revenue. In the last year, the revenue decreased by -5.86%.
B7E shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)172.52%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%234.37%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%4.56%

3.2 Future

Based on estimates for the next years, B7E will show a very negative growth in Earnings Per Share. The EPS will decrease by -49.11% on average per year.
Based on estimates for the next years, B7E will show a small growth in Revenue. The Revenue will grow by 3.43% on average per year.
EPS Next Y-81.13%
EPS Next 2Y-49.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.09%
Revenue Next 2Y3.28%
Revenue Next 3Y6.51%
Revenue Next 5Y3.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.84 indicates a rather cheap valuation of B7E.
Based on the Price/Earnings ratio, B7E is valued cheaper than 95.69% of the companies in the same industry.
When comparing the Price/Earnings ratio of B7E to the average of the S&P500 Index (27.91), we can say B7E is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 19.57, the valuation of B7E can be described as rather expensive.
64.66% of the companies in the same industry are more expensive than B7E, based on the Price/Forward Earnings ratio.
B7E's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.11.
Industry RankSector Rank
PE 5.84
Fwd PE 19.57
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

B7E's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. B7E is cheaper than 94.83% of the companies in the same industry.
85.34% of the companies in the same industry are more expensive than B7E, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.66
EV/EBITDA 3.66
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

B7E has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as B7E's earnings are expected to decrease with -49.11% in the coming years.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-49.11%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.80%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.67, B7E pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, B7E pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.8%

5.2 History

The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

B7E pays out 21.99% of its income as dividend. This is a sustainable payout ratio.
B7E's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP21.99%
EPS Next 2Y-49.11%
EPS Next 3YN/A
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
B7E.DE Dividend Payout.B7E.DE Dividend Payout, showing the Payout Ratio.B7E.DE Dividend Payout.PayoutRetained Earnings

BLUE CAP AG

FRA:B7E (7/29/2025, 1:10:01 PM)

17

-0.2 (-1.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-20 2025-08-20
Inst Owners25.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap76.33M
Analysts82.86
Price Target30.6 (80%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.8%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP21.99%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.84
Fwd PE 19.57
P/S 0.37
P/FCF 9.66
P/OCF 5.87
P/B 0.8
P/tB 1.71
EV/EBITDA 3.66
EPS(TTM)2.91
EY17.12%
EPS(NY)0.87
Fwd EY5.11%
FCF(TTM)1.76
FCFY10.35%
OCF(TTM)2.89
OCFY17.03%
SpS45.86
BVpS21.18
TBVpS9.95
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 13.94%
ROCE 5.68%
ROIC 3.95%
ROICexc 6.3%
ROICexgc 13.24%
OM 4.18%
PM (TTM) 6.44%
GM 50.05%
FCFM 3.84%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexcg growth 3Y54.39%
ROICexcg growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 9.68
Debt/EBITDA 1.4
Cap/Depr 29.84%
Cap/Sales 2.47%
Interest Coverage 1.83
Cash Conversion 50.62%
Profit Quality 59.6%
Current Ratio 1.65
Quick Ratio 1.36
Altman-Z 2.15
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)172.52%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%234.37%
EPS Next Y-81.13%
EPS Next 2Y-49.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%4.56%
Revenue Next Year2.09%
Revenue Next 2Y3.28%
Revenue Next 3Y6.51%
Revenue Next 5Y3.43%
EBIT growth 1Y33.24%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-23.35%
EBIT Next 3Y-2.93%
EBIT Next 5Y-2.15%
FCF growth 1Y-21.47%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-11.77%
OCF growth 3Y1.47%
OCF growth 5Y47.8%